Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients.
Anti-epidermal growth factor receptor (EGFR) therapy has been tried in triple negative breast cancer (TNBC) patients without evaluation of molecular and clinical predictors in several randomized clinical studies. Only fewer than 20% of metastatic TNBCs showed response to anti-EGFR therapy. In order...
Main Authors: | Yoonjung Kim, Juwon Kim, Hy-De Lee, Joon Jeong, Woochang Lee, Kyung-A Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3813621?pdf=render |
Similar Items
-
Correction: Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients
Published: (2014-01-01) -
Correction: Spectrum of Gene Copy Number Changes and Gene Mutation Status in Korean Triple Negative Breast Cancer Patients.
Published: (2014-01-01) -
Copy number variation of age-related macular degeneration relevant genes in the Korean population.
by: Jung Hyun Park, et al.
Published: (2012-01-01) -
Gefitinib and EGFR gene copy number aberrations in esophageal cancer
by: Petty, RD, et al.
Published: (2017) -
Pathological Factors Affecting DNA Quality in BRAF, EGFR, and KRAS Gene Molecular Tests
by: Hyon-Goo Yun, et al.
Published: (2020-12-01)